Schweitzer Biotech Company Ltd. (SBC) is a dynamic and innovative company dedicated to developing new solutions that contribute to the wellbeing of humans, animals, and the environment.
With more than 40 years of experience in the development, production, and registration of vaccines for animal diseases, SBC takes pride in providing its global customers with breakthrough technologies to accomplish their goals and strengthen their market position.
SBC has collaborated with the world’s top 10 animal health companies and built an excellent reputation in animal disease prevention and control.
In recent years, SBC has diversified its business activities to animal disease diagnostics, human vaccines, dietary supplements, and environmentally friendly technologies.
|2001||Schweitzer Biotech Company Ltd. was estabilsed.|
|2005||Cooperated with a China pharmaceutical company, Pulike, to technical transfer the PRRS, PCV2 and CSF vaccines, and assisted Pulike in the production and market development.|
|2011||Joint venture with Virbac (France)|
|2016||Developed cPCR diagnostic kit and machine for China and European pharmaceutical company; Weider probiotics sold through Costco record high.|
|2019||Developed ASF diagnostic kit and validated by Pirbright, OIE reference lab; Weider probiotics sold to Japan & China.|
|2020||Developed COVID-19 nucleic acid diagnostic kits and obtained CE mark certification, IgM/IgG antibody raid test kit, and IgM/IgG antibody ELISA kit.|